These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6403924)

  • 21. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recurrent bleeding tendency due to factor VIII inhibitor during therapy for bullous pemphigoid].
    Kuboki T; Kudo T; Iwata N; Morimoto I
    Rinsho Ketsueki; 1999 Oct; 40(10):1087-92. PubMed ID: 10565226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP; Gaillandre A; Frommel D
    Thromb Haemost; 1981 Jun; 45(3):285-9. PubMed ID: 6792741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of patients with factor VIII autoantibodies by staphylococcal protein A-based immunoadsorption and immunosuppression.
    Mansouri Taleghani B; Grossmann R
    Br J Haematol; 2001 Sep; 114(4):956-8. PubMed ID: 11564094
    [No Abstract]   [Full Text] [Related]  

  • 25. Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb).
    Knöbl P; Derfler K; Korninger L; Kapiotis S; Jäger U; Maier-Dobersberger T; Hörl W; Lechner K; Pabinger I
    Thromb Haemost; 1995 Oct; 74(4):1035-8. PubMed ID: 8560408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful management of a patient with an acquired factor VIII inhibitor.
    Sultan Y; Maisonneuve P; Bismuth A; Steg A
    Transfusion; 1983; 23(1):62-4. PubMed ID: 6402833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inhibitor of antihemophilic factor (factor VIII) in an 18-month-old nonhemophilic child.
    Stein J; Ratnoff OD
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):346-50. PubMed ID: 8328652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasma and plasma fractions in the therapy of blood coagulation disorders].
    Lechler E
    Internist (Berl); 1974 Sep; 15(9):461-4. PubMed ID: 4609113
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunocoagulopathies as a possible cause of acquired hemorrhagic diathesis].
    Klare M; Möller T; Hanke P; Weller P; Seige K
    Z Gesamte Inn Med; 1983 May; 38(10):277-80. PubMed ID: 6412468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Why does a man have bruises after sawing wood in order to warm up the sauna?].
    Kauppila M; Mäkipernaa A
    Duodecim; 2003; 119(17):1669-71. PubMed ID: 14587447
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody.
    Berger JR; Rosenfeld WE; Sheremata WA; Lian EC; Ayyar DR; Melo J; Kloss K
    Neurology; 1983 Sep; 33(9):1224-6. PubMed ID: 6412159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
    Walsh JD; Landercasper J; Bottner WA; Boyd WC
    Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors.
    Ewenstein BM; Hoots WK; Lusher JM; DiMichele D; White GC; Adelman B; Nadeau K
    Haematologica; 2000 Oct; 85(10 Suppl):35-9. PubMed ID: 11187868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe bleeding in a case of acquired factor VIII inhibitor associated with generalized pustular psoriasis.
    Merlini M; Moccia F; Delucchi M; Grillo G
    Ann Ital Med Int; 2005; 20(4):248-52. PubMed ID: 16610257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of polyelectrolyte-fractionated porcine factor VIII in the treatment of a spontaneously acquired inhibitor to factor VIII.
    Hultin MB; Hennessey J
    Thromb Res; 1989 Jul; 55(1):51-6. PubMed ID: 2506662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor].
    Turkstra F; Levi M; Koopman MM; Wester JP; Stoutenbeek CP; Briët E
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1464-7. PubMed ID: 9752060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].
    Kubota Y; Sano M; Nakazato S; Tsuneyoshi N; Tomimasu R; Kuwahara N; Fukushima N; Funai N; Suga K; Sueoka E
    Rinsho Ketsueki; 2004 Sep; 45(9):1023-7. PubMed ID: 15510829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired factor VIII inhibitor in a patient with dermatomyositis--a case study.
    Ayoola A; Mohsini W; Aung S
    Acta Haematol; 2008; 119(1):8-11. PubMed ID: 18176073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.